skip to content : skip to contact information
homenewseducationresearchoffices+servicescommunityeventsaboutmap search
research labs, centers and programs
Vials of lipid-like molecules developed by a team from MIT and Alnylam Pharmaceuticals. Some of the compounds have successfully delivered RNA interference agents in animals. spotlight: Genetic Therapy. A team of researchers from MIT and Alnylam Pharmaceuticals has developed safe and effective methods to perform RNA interference, a therapy that holds great promise for treating a variety of diseases including cancer and hepatitis. Scientists see RNA interference (RNAi) as a way to turn off specific disease-causing genes.
 
  view list by name:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P Q | R | S | T | U | V | W X Y Z
  Home - MIT view list by topic:
Aeronautical and astronautical engineering
Architecture
Anthropology
Arts
Astronomy
Biology and bioengineering
Business and management
Cancer
Chemistry and chemical engineering
Civil and environmental engineering
Cognitive science
Computer sciences
Earth and atmospheric sciences
Economics
 Educational technology
Electrical engineering
Entrepreneurship and invention
Energy
History
Humanities
International studies
Languages and literature
Libraries
Linguistics
Media arts and sciences
Materials sciences and engineering
Mathematics
Mechanical engineering
 Medical sciences
Music
Nanoscience and nanotechnology
Neuroscience
Nuclear engineering
Oceanography and ocean engineering
Physics
Philosophy
Political science
Resources for researchers
Robotics and artificial intelligence
Social sciences
Technology and society
Urban studies and planning